Insights
Where Raquel shares her thinking on regulatory strategy, regulatory science, innovation and AI in life sciences, both on stage and in print.
Events & Speaking
Raquel joins industry forums, conferences, and academic programs as a speaker, panelist and moderator. Reach out for speaking invitations.
Upcoming · 2026
Self-Care as a Mechanism for Resilience, Sustainability and Health Protection
Raquel will join leaders from public health, academia and industry to discuss the role of self-care in strengthening health-system resilience, sustainability and health protection across Latin America.
Past Engagements
Past · 2025
Empowering Women’s Health: Navigating Global Regulatory Challenges and Innovations
Raquel joined global regulatory and industry leaders to explore how scientific advances, new technologies and evolving regulatory frameworks are shaping women’s health, and the strategies needed to support innovation across markets.
Past · 2025
Beyond the Label: Reinventing Consumer Trust and Innovation in Self-Care
Raquel moderated a senior-leader discussion on how science, credible benefits and consumer understanding build trust in self-care, exploring e-commerce self-selection, evolving regulatory categories, health literacy and misinformation in the AI era.
Past · 2025
AI in Life Sciences & Healthcare: Balancing Innovation, Regulation, and Real-World Impact
Raquel joined leaders from industry and government to discuss how AI is transforming drug discovery and healthcare, with a focus on balancing innovation with evolving regulatory expectations, ethical considerations, translational challenges and real-world impact.
Past · 2025
The Use of Artificial Intelligence in the Regulatory Environment
Raquel explored the use of AI in the regulatory environment as part of a broader discussion on innovation, self-care and the evolution of a more sustainable and effective health system in Brazil.
Past · 2025
AI as a Democratization, Safety and Regulatory Empowerment Tool in Nonprescription Health
Raquel presented insights on how AI can advance regulatory science and public health for nonprescription medicines in Latin America, exploring its potential to expand access, strengthen safety and empower regulatory decision-making. The forum brought together regulators, legislators, academia, health organizations and the self-care industry from across the region.
Past · 2025
Pharmacotherapy for Minors: Pediatric Drug Development from Good Intentions to Global Abuse
Raquel joined an interdisciplinary panel examining the scientific, regulatory and ethical complexities of pediatric drug development, including global clinical research, research oversight, informed consent and the protection of vulnerable populations.
Research & Benchmarking
Original RGM research exploring the forces reshaping life sciences, consumer health, regulatory strategy and organizational capabilities.
A benchmarking study exploring how consumer healthcare organizations are responding to a changing environment, and the capabilities, organizational choices and priorities shaping the next generation of the industry.
Drawing on perspectives from industry leaders, the study examines emerging shifts across innovation, regulatory and scientific capabilities, operating models, technology and the evolving expectations of consumers and healthcare systems.
Articles & Perspectives
Raquel shares perspectives on regulatory strategy, regulatory science, innovation, AI and the forces reshaping life sciences.
An examination of FDA’s evolving approach to publishing Complete Response Letters, and the balance between regulatory transparency, protection of confidential information, and the opportunity to advance regulatory learning and better drug development.
A review of 50 public comments submitted to FDA on expanding access to nonprescription medicines, highlighting areas of stakeholder alignment, emerging policy questions, and how digital and direct-to-patient models are changing the broader medication-access landscape.
A perspective on the forces reshaping life sciences, including the expanding role of AI, evolving regulatory expectations, innovation in women’s health, and the increasing need for R&D and regulatory leaders to anticipate change and build new capabilities.
Media & Features
Selected external coverage of Raquel’s work across regulatory science, R&D leadership, life sciences and academia.
Rutgers introduces its new MBS Regulatory Science concentration, with Raquel serving as an advisor to the concentration and instructor of Fundamentals of Regulatory Affairs. The program connects regulatory science with business, leadership and product development across pharmaceuticals, food and cosmetics.
Coverage of an interdisciplinary Research Month panel featuring Raquel and leaders in medicine, bioethics and pharmaceutical science discussing the scientific, regulatory and ethical complexities of pediatric drug development.
PharmaVoice features Raquel among senior life sciences leaders, highlighting her leadership philosophy of recognizing potential in others and creating the conditions for people and teams to excel.
An executive profile exploring Raquel’s strategic perspective spanning Regulatory Affairs and R&D, her leadership journey, and her perspectives on leadership and opportunities for women in life sciences.
Academic Affiliations
Raquel contributes to the next generation of life sciences leaders through academic teaching and program involvement.
Rutgers University
Master of Business & Science Program
Raquel coordinates the Regulatory Science concentration and teaches Fundamentals of Regulatory Affairs, advising graduate students and bringing current industry practice and innovation perspective into the program.
